1. Home
  2. KKR vs BSX Comparison

KKR vs BSX Comparison

Compare KKR & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KKR
  • BSX
  • Stock Information
  • Founded
  • KKR 1976
  • BSX 1979
  • Country
  • KKR United States
  • BSX United States
  • Employees
  • KKR N/A
  • BSX N/A
  • Industry
  • KKR Investment Managers
  • BSX Medical/Dental Instruments
  • Sector
  • KKR Finance
  • BSX Health Care
  • Exchange
  • KKR Nasdaq
  • BSX Nasdaq
  • Market Cap
  • KKR 147.0B
  • BSX 129.7B
  • IPO Year
  • KKR 2010
  • BSX 1992
  • Fundamental
  • Price
  • KKR $132.24
  • BSX $104.50
  • Analyst Decision
  • KKR Strong Buy
  • BSX Strong Buy
  • Analyst Count
  • KKR 14
  • BSX 23
  • Target Price
  • KKR $161.43
  • BSX $107.23
  • AVG Volume (30 Days)
  • KKR 4.7M
  • BSX 6.0M
  • Earning Date
  • KKR 02-04-2025
  • BSX 02-05-2025
  • Dividend Yield
  • KKR 0.53%
  • BSX N/A
  • EPS Growth
  • KKR N/A
  • BSX 16.82
  • EPS
  • KKR 3.28
  • BSX 1.25
  • Revenue
  • KKR $26,574,524,000.00
  • BSX $16,747,000,000.00
  • Revenue This Year
  • KKR N/A
  • BSX $13.40
  • Revenue Next Year
  • KKR $18.77
  • BSX $10.23
  • P/E Ratio
  • KKR $40.31
  • BSX $83.63
  • Revenue Growth
  • KKR 42.39
  • BSX 17.61
  • 52 Week Low
  • KKR $91.92
  • BSX $65.52
  • 52 Week High
  • KKR $170.40
  • BSX $107.17
  • Technical
  • Relative Strength Index (RSI)
  • KKR 28.58
  • BSX 63.53
  • Support Level
  • KKR $137.84
  • BSX $102.92
  • Resistance Level
  • KKR $142.69
  • BSX $106.72
  • Average True Range (ATR)
  • KKR 5.23
  • BSX 1.72
  • MACD
  • KKR -2.23
  • BSX -0.46
  • Stochastic Oscillator
  • KKR 4.14
  • BSX 58.73

About KKR KKR & Co. Inc.

KKR is one of the world's largest alternative asset managers, with $624.4 billion in total managed assets, including $505.7 billion in fee-earning AUM, at the end of September 2024. The company has two core segments: asset management (which includes private markets—private equity, credit, infrastructure, energy, and real estate—and public markets—primarily credit and hedge/investment fund platforms) and insurance (following the firm's initial investment in, and then ultimate purchase of, Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance).

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Share on Social Networks: